Molecular Imaging: Page 131

Navidea raises $7.6M, regains listing compliance

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals announced that it has raised funds totaling $7.6 million from two transactions. At the same time, the company announced that it was back in compliance with listing standards on the NYSE American Stock Exchange.

February 16, 2020

FDG-PET/CT points to cervical cancer patient outcomes

By Wayne Forrest

Several indicators on pretreatment FDG-PET/CT scans can help predict overall survival in patients with locally advanced cervical cancer and para-aortic lymph node involvement. The markers could help clinicians steer patients toward more aggressive treatment, according to a February 7 study in Journal of Nuclear Medicine.

February 12, 2020

MIM Software, Sitex team up to treat cancer

By AuntMinnie.com staff writers

Medical imaging software developer MIM Software will collaborate with radiation oncology firm Sirtex Medical to distribute yttrium-90 (Y-90) microspheres and related products around the world.

February 11, 2020

NorthStar inks supply deal with Clarity

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes parent NorthStar Medical Technologies has signed a letter of intent to supply radiopharmaceutical firm Clarity Pharmaceuticals with copper-67.

February 11, 2020

PET shows cardiac meds may reduce beta-amyloid buildup

By Wayne Forrest

Patients who were on cardiovascular medications like cholesterol-lowering drugs seem to have lower levels of amyloid burden on PET scans, according to a study published February 7 in JAMA Network Open. The question is whether these findings indicate the individuals are at lower risk for Alzheimer's disease.

February 11, 2020

International Isotopes receives FDA nod for I-131

By AuntMinnie.com staff writers

Radioisotope manufacturer International Isotopes received clearance from the U.S. Food and Drug Administration (FDA) for use of its sodium iodide-131 (I-131) radiopharmaceutical to treat hyperthyroidism and thyroid carcinomas.

February 10, 2020

Eckert & Ziegler to open U.S. isotope facility

By AuntMinnie.com staff writers

Isotope technology firm Eckert & Ziegler has unveiled plans to open a radiopharmaceutical production site in Massachusetts.

February 5, 2020

FDG-PET shows where exercise could stall Alzheimer's

By Wayne Forrest

People with sedentary lifestyles who exercised regularly over several months showed increased brain glucose metabolism on FDG-PET in one brain region associated with the early onset of dementia or Alzheimer's disease, according to a study published online February 3 in Brain Plasticity.

February 5, 2020

Collaboration aims to detect neurodegenerative diseases

By AuntMinnie.com staff writers

A new collaboration between Fuzionaire Diagnostics, McGill University, and Montreal Neurological Institute and Hospital seeks to better detect and treat neurological diseases.

January 29, 2020

Amyloid-PET advocates take their case to Congress

By Wayne Forrest

Proponents of a bill pending in the U.S. Congress that would ensure adequate reimbursement for diagnostic radiopharmaceuticals for use with PET to diagnose Alzheimer's disease and other neurodegenerative conditions took their cause to the nation's capital on January 29.

January 29, 2020

FDA OKs trials for MS PET tracer

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has approved human trials for a new PET radiotracer that could help diagnose multiple sclerosis (MS) in its early stages.

January 28, 2020

Jubilant gets Health Canada nod for Drax Exametazime

By AuntMinnie.com staff writers

Jubilant Radiopharma has garnered Health Canada clearance for Drax Exametazime, a kit for preparing technetium-99m exametazime for leukocyte labeling.

January 27, 2020

Previous Page

Page 131 of 620

Next Page